Multiple Dose Trial of Anti-glycation Agent GLY-230 in Healthy and Diabetic Subjects

Clinical trial NCT00544934 · COMPLETED

Trial details

NCT number: NCT00544934
Sponsor: Glycadia
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Diabetic Nephropathy

Start date: 2007-02-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.